NO163617C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.Info
- Publication number
- NO163617C NO163617C NO842821A NO842821A NO163617C NO 163617 C NO163617 C NO 163617C NO 842821 A NO842821 A NO 842821A NO 842821 A NO842821 A NO 842821A NO 163617 C NO163617 C NO 163617C
- Authority
- NO
- Norway
- Prior art keywords
- pyrrolidinon
- derivatives
- preparation
- therapeutic active
- analogue procedure
- Prior art date
Links
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical class O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/50—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
- C07C205/51—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8311636A FR2549053B1 (fr) | 1983-07-12 | 1983-07-12 | Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant |
Publications (3)
Publication Number | Publication Date |
---|---|
NO842821L NO842821L (no) | 1985-01-14 |
NO163617B NO163617B (no) | 1990-03-19 |
NO163617C true NO163617C (no) | 1990-06-27 |
Family
ID=9290775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO842821A NO163617C (no) | 1983-07-12 | 1984-07-11 | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater. |
Country Status (23)
Country | Link |
---|---|
US (1) | US4604383A (no) |
EP (1) | EP0135406B1 (no) |
JP (1) | JPS6084265A (no) |
KR (1) | KR910003362B1 (no) |
AR (1) | AR240451A1 (no) |
AT (1) | ATE30150T1 (no) |
AU (1) | AU560725B2 (no) |
CA (1) | CA1249593A (no) |
DD (2) | DD227962A5 (no) |
DE (1) | DE3466686D1 (no) |
DK (1) | DK343784A (no) |
ES (1) | ES8504122A1 (no) |
FI (1) | FI77848C (no) |
FR (1) | FR2549053B1 (no) |
GR (1) | GR81502B (no) |
HU (1) | HU192564B (no) |
IL (1) | IL72324A (no) |
NO (1) | NO163617C (no) |
NZ (1) | NZ208865A (no) |
PT (1) | PT78874B (no) |
SU (1) | SU1391497A3 (no) |
YU (2) | YU121384A (no) |
ZA (1) | ZA845397B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3336024A1 (de) * | 1983-10-04 | 1985-04-18 | Boehringer Ingelheim KG, 6507 Ingelheim | 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel |
ES2043943T3 (es) * | 1988-05-20 | 1994-01-01 | Zambon Spa | Procedimiento para la preparacion de compuestos con actividad analgesica central. |
GB9307431D0 (en) * | 1993-04-08 | 1993-06-02 | Oxford Asymmetry Ltd | Improvements in or relating to chiral auxiliaries |
CN106977415B (zh) * | 2016-01-15 | 2021-03-26 | 广东东阳光药业有限公司 | 一种沙库必曲的中间体及其制备方法 |
WO2017148357A1 (zh) * | 2016-02-29 | 2017-09-08 | 广东东阳光药业有限公司 | 一种沙库必曲的中间体及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3272842A (en) * | 1965-06-25 | 1966-09-13 | Lilly Co Eli | Novel pyrrolinones |
AU518986B2 (en) * | 1977-10-11 | 1981-10-29 | Takeda Chemical Industries Ltd. | Lactams |
FR2436779A1 (fr) * | 1978-09-22 | 1980-04-18 | Pharmindustrie | Derives de pyrrolidine-2 methanol utilisables comme medicaments |
-
1983
- 1983-07-12 FR FR8311636A patent/FR2549053B1/fr not_active Expired
-
1984
- 1984-07-03 AU AU30216/84A patent/AU560725B2/en not_active Ceased
- 1984-07-04 DE DE8484401419T patent/DE3466686D1/de not_active Expired
- 1984-07-04 CA CA000458049A patent/CA1249593A/en not_active Expired
- 1984-07-04 EP EP84401419A patent/EP0135406B1/fr not_active Expired
- 1984-07-04 AT AT84401419T patent/ATE30150T1/de not_active IP Right Cessation
- 1984-07-05 US US06/628,211 patent/US4604383A/en not_active Expired - Fee Related
- 1984-07-06 IL IL72324A patent/IL72324A/xx unknown
- 1984-07-09 GR GR75247A patent/GR81502B/el unknown
- 1984-07-10 PT PT78874A patent/PT78874B/pt not_active IP Right Cessation
- 1984-07-11 SU SU843764652A patent/SU1391497A3/ru active
- 1984-07-11 AR AR297160A patent/AR240451A1/es active
- 1984-07-11 HU HU842710A patent/HU192564B/hu not_active IP Right Cessation
- 1984-07-11 DD DD84265162A patent/DD227962A5/de not_active IP Right Cessation
- 1984-07-11 DD DD84276870A patent/DD229121A5/de not_active IP Right Cessation
- 1984-07-11 NO NO842821A patent/NO163617C/no unknown
- 1984-07-11 FI FI842795A patent/FI77848C/fi not_active IP Right Cessation
- 1984-07-11 ES ES534221A patent/ES8504122A1/es not_active Expired
- 1984-07-11 YU YU01213/84A patent/YU121384A/xx unknown
- 1984-07-11 NZ NZ208865A patent/NZ208865A/en unknown
- 1984-07-12 ZA ZA845397A patent/ZA845397B/xx unknown
- 1984-07-12 KR KR1019840004083A patent/KR910003362B1/ko active IP Right Grant
- 1984-07-12 JP JP59143423A patent/JPS6084265A/ja active Pending
- 1984-07-12 DK DK343784A patent/DK343784A/da not_active Application Discontinuation
-
1986
- 1986-05-16 YU YU00810/86A patent/YU81086A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO164025C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. | |
NO156785C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater. | |
NO159016C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater. | |
NO883974L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
NO165239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater. | |
NO165192C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater. | |
NO161497C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. | |
NO165027C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive propenyl-cefalosporinforbindelser. | |
NO874153D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater. | |
NO157296C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(4-indolyl-piperidino-alkyl)-benzimidazolon-derivater. | |
NO158876C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater. | |
NO161317C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer. | |
NO841542L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater | |
NO161562C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater. | |
NO164541C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. | |
NO158460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
NO155771C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater. | |
NO158941C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater. | |
NO159090C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater. | |
NO163570C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner. | |
NO158800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater. | |
NO156167C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater. | |
NO162188C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner. | |
NO163617C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater. | |
NO157618C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamid-inderivater. |